Heron Therapeutics, Inc. (HRTX): Price and Financial Metrics
HRTX Price/Volume Stats
| Current price | $2.59 | 52-week high | $3.22 |
| Prev. close | $2.64 | 52-week low | $0.50 |
| Day low | $2.58 | Volume | 2,089,300 |
| Day high | $2.71 | Avg. volume | 2,757,605 |
| 50-day MA | $2.74 | Dividend yield | N/A |
| 200-day MA | $1.76 | Market Cap | 389.35M |
HRTX Stock Price Chart Interactive Chart >
Heron Therapeutics, Inc. (HRTX) Company Bio
Heron Therapeutics is a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs. The company was founded in 1983 and is based in Redwood City, CA.
Latest HRTX News From Around the Web
Below are the latest news stories about HERON THERAPEUTICS INC that investors may wish to consider to help them evaluate HRTX as an investment opportunity.
Miyazaki's 'The Boy and the Heron' is No. 1 at the box office, a first for the Japanese anime masterFor the first time in Hayao Miyazaki's decades-spanning career, the 82-year-old Japanese anime master is No. 1 at the North American box office. “The Boy and the Heron,” the long-awaited animated fantasy from the director of “Spirited Away,” “My Neighbor Totoro” and other cherished anime classics, is only the third anime to ever top the box office in U.S. and Canadian theaters, and the first original anime to do so. The film, which is playing in both subtitled and dubbed versions, is also the first fully foreign production to land atop the domestic box office this year. |
13 Hot Penny Stocks To Buy According to Hedge FundsIn this article, we will take a look at the 13 Hot Penny Stocks To Buy According to Hedge Funds. To see more hot penny stocks, go directly to 5 Hot Penny Stocks To Buy According to Hedge Funds. The overall market optimism helped by expectations that the Fed might start cutting interest rates in […] |
Penny Stock Powerhouses: 7 Picks Poised for Explosive GrowthUndeniably, the concept of growth penny stocks represent one of the hottest topics on Wall Street. |
CEO & Director of Heron Therapeutics Craig Collard Buys 411% More SharesInvestors who take an interest in Heron Therapeutics, Inc. ( NASDAQ:HRTX ) should definitely note that the CEO... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayIt's time to dive into the biggest pre-market stock movers as we check out all of the hottest news worth reading about on Wednesday! |
HRTX Price Returns
| 1-mo | -12.79% |
| 3-mo | -0.96% |
| 6-mo | 330.38% |
| 1-year | -2.63% |
| 3-year | -85.03% |
| 5-year | -89.11% |
| YTD | 52.35% |
| 2023 | -32.00% |
| 2022 | -72.62% |
| 2021 | -56.86% |
| 2020 | -9.94% |
| 2019 | -9.41% |
Continue Researching HRTX
Here are a few links from around the web to help you further your research on Heron Therapeutics Inc's stock as an investment opportunity:Heron Therapeutics Inc (HRTX) Stock Price | Nasdaq
Heron Therapeutics Inc (HRTX) Stock Quote, History and News - Yahoo Finance
Heron Therapeutics Inc (HRTX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...